Skip to content
mapperlab
← Dashboard
Stock

HNGE

Hinge Health, Inc.
Latest close $596 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
9
Current + past
New this quarter
0
Exited this quarter
1

Marquee-fund ownership over time

Aug 14, 2025Nov 13, 2025Feb 17, 2026May 15, 2026
Now
6

This quarter's activity

New positions opened

None.

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Citadel Advisors$57$59+4%
Two Sigma Investments$57$59+4%
Millennium Management$57$59+4%
Point72 Asset Management$57$59+4%
Renaissance Technologies$42$59+42%
D.E. Shaw$39$59+52%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Tiger Global→ $55-5%
Coatue Management→ $39-31%
Soros Fund Management→ $39-32%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Hinge Health, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
16
Filings · last 90d
27
Total on file
70
Recent SEC buffer
Most recent
Jun 5, 2026

30d / 90d windows measured from Jun 5, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 70 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Hinge Health, Inc.

Annual figures sourced directly from Hinge Health, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$587.86M
FY2025+51% YoY
Net income
-$528.26M
FY2025-500%+ YoY
EPS (diluted)
$-7.77
FY2025-500%+ YoY
Free cash flow(?)
$170.73M
FY2025+256% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Hinge Health, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
D.E. ShawQ1 2026open$39$55+40%
Renaissance TechnologiesQ4 2025open$42$55+31%
Tiger GlobalQ3 2025Q2 2026$57$55-5%
Citadel AdvisorsQ3 2025open$57$55-4%
Soros Fund ManagementQ3 2025Q1 2026$57$39-32%
Two Sigma InvestmentsQ3 2025open$57$55-4%
Coatue ManagementQ3 2025Q1 2026$57$39-31%
Millennium ManagementQ3 2025open$57$55-4%
Point72 Asset ManagementQ3 2025open$57$55-4%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.